Stay updated with breaking news from Medication Control. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HIWU Relaunches Anonymous Whistleblower Platforms in Partnership with RealResponse; Platforms Now Accepting Tips for both ADMC and Racetrack Safety Programs
HISA Anti-Doping and Medication Control Program to Relaunch May 22, 2023, Under Enforcement of HIWU
Mofebutazone is an analogue of phenylbutazone exhibiting a non-steroidal anti-inflammatory (NSAID) mechanism of action.
With safety concerns at the forefront head of the 148th running of The Preakness Stakes, veterinarians and gaming officials discussed protocols in place to protect riders and the horses.
A federal judge denied a motion for an injunction by the National HBPA to prevent HISA's Anti-Doping and Medication Control program from going into effect May 22.